Physician

Adelynn Vera Gerstenberger, P.A.

According to 2025 Medicare claims, Adelynn Gerstenberger, P.A. (NPI: 1861642910) practices physician assistant in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP COASTAL REGION, LLC (NPI: 1750976809; TIN: 861441258) and primary practice location at 28401-7407. Gerstenberger is affiliated with the Physician Quality Partners, LLC (ACO ID: A2778) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gerstenberger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 408 traditional Medicare patients, billed 761 HCPCS/CPT codes, and received $47,090 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 570 prescription claims across 220 beneficiaries totaling $480,168 in drug costs, led by Xarelto (Rivaroxaban). 2021 DME data shows 74 claims. Open Payments data shows 21 records totaling $473. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $72,854 to $47,090. In contrast, Part D prescription costs have risen steadily, from $13,905 to $480,168. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $2,070 and ending at $3,859.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	455	1,307	$72,854
2016	411	1,305	$73,172
2017	368	1,075	$63,583
2018	362	1,263	$77,348
2019	359	1,226	$78,266
2020	247	975	$60,712
2021	165	691	$52,906
2022	171	568	$42,479
2023	340	706	$43,932
2024	408	761	$47,090

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	117	315	$13,905
2016	103	278	$17,308
2017	96	240	$20,617
2018	84	207	$8,268
2019	95	290	$17,327
2020	61	174	$13,392
2021	N/R	15	$2,752
2022	15	24	$25,480
2023	140	281	$185,022
2024	220	570	$480,168

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$936
2017	20	185	$6,923
2018	17	124	$5,209
2019	13	95	$3,907
2020	28	138	$7,061
2021	N/R	74	$3,859
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	12	12	$115
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	49	51	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	328	613	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	78	80	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	23	690	$13,609
Dexamethasone	Dexamethasone	34	752	$577
Letrozole	Letrozole	17	810	$402
Oxycodone Hcl	Oxycodone Hcl	32	499	$371
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	384	$295

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$473	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adelynn Vera Gerstenberger, P.A.?

Tedicare shows public-source Medicare data for Adelynn Vera Gerstenberger, P.A. (NPI 1861642910), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adelynn Vera Gerstenberger, P.A. have ACO affiliation data?

Adelynn Vera Gerstenberger, P.A. is shown with ACO affiliation data for Physician Quality Partners, LLC (MSSP, ACO ID A2778) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Adelynn Vera Gerstenberger, P.A.?

Adelynn Vera Gerstenberger, P.A. is linked to NOVANT HEALTH MEDICAL GROUP COASTAL REGION, LLC (billing NPI 1750976809) in the available physician profile data.

Does Adelynn Vera Gerstenberger, P.A. have Open Payments data?

Adelynn Vera Gerstenberger, P.A. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.